Status:
ACTIVE_NOT_RECRUITING
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This trial studies how well a text-based intervention works in improving adherence to hormone therapy in patients with stage I-III hormone receptor positive breast cancer. Women often require long ter...
Detailed Description
PRIMARY OBJECTIVES: I. Examine the efficacy of messaging for adjuvant hormone therapy compliance promotion (mAHT-CaP) in a randomized control trial (RCT) design. SECONDARY OBJECTIVES: I. Conduct me...
Eligibility Criteria
Inclusion
- Woman diagnosed with stage I-III breast cancer (BCa).
- Hormone receptor positive tumor.
- Completed local definitive treatment (i.e., surgery chemotherapy, radiation).
- Within 3 month of initiation of a new adjuvant hormonal therapy (AHT) regimen.
- At least 12 months of AHT recommended.
- Able to read and understand English.
- Able to provide informed consent.
- Have a mobile device with text (TXT) capability.
- Know or willing to learn how to use TXT.
Exclusion
- • Cognitive impairment documented in the electronic medical record (EMR), biological variables (sex).
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2024
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT04086875
Start Date
November 7 2018
End Date
September 24 2024
Last Update
June 10 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Health - South Jersey
Sewell, New Jersey, United States, 08080
2
Jefferson Health - Abington
Abington, Pennsylvania, United States, 19001
3
Doylestown Hospital
Doylestown, Pennsylvania, United States, 18901
4
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107